Mumbai, July 16, 2014 – The Board of Directors of Unichem Laboratories Ltd at their meeting held on July 12, 2014 approved the First Quarter (Q1) Un-audited Results for FY 2014-15.
The Company’s standalone revenue from operations stood at Rs. 290.99 crs for the quarter ended June 30, 2014 against Rs. 265.57 crs recorded during the corresponding quarter of the previous year, reflecting a growth of 9.6%.
The Company’s EBITDA for the quarter stood at Rs. 43.68 crs.
The Company recorded a Net Profit After Tax of Rs. 30.19 Crores for the quarter ended June 30, 2014 as against Rs. 36.09 Crores in the corresponding quarter of the previous year.
The EPS-Diluted for the current quarter stood at Rs. 3.32 (corresponding quarter previous year: Rs. 3.98). BWI
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…